Art

J-GLOBAL ID：201702281427492128   Reference number：17A0461367

胃癌における腫瘍内分子生物学的heterogeneityと治療抵抗性機序の解明および新たな治療戦略の開発

Author (3)： WAKATSUKI TAKERU (がん研究会 有明病院 消化器化学療法科) ,  YAMAMOTO CHIRIKO (がん研究会) ,  MASHIMA TETSUO (がん研究会 化学療法セ)
Material： 大和証券ヘルス財団研究業績集
Volume： 40  Page： 59-63  Publication year： Mar. 10, 2017 
JST Material Number： S0242B  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： *stomach tumor ,...
Semi thesaurus term： *HER-2 ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0461367&from=J-GLOBAL&jstjournalNo=S0242B") }}

JST classification (2)： Tumors(=neoplasms)of digestive system  (GH04000D) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C)

Reference (7)：

• M. Hofmann, O. Stoss, T. Gaiser, H. Kneitz, P. Heinmoller, T. Gutjahr, M. Kaufmann, T. Henkel, J. Ruschoff, Central HER2 IHC and FISH analysis in a trastuzumab ( Herceptin ) phase II monotherapy study: assessment of test sensitivity and impact of chromosome 17 polysomy, Journal of clinical pathology, 61 (2008) 89-94.
• Y. Kang, Shah MA, Ohtsu A, et al., A randomized, open-label, multicenter, adaptive phase 2/3 study of trastuzumab emtansine (T-DM1) versus a taxane (TAX) in patients (pts) with previously treated HER2-positive locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma (LA/MGC/GEJC). Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 34 (2016) .
• Y. Kuboki, S. Yamashita, T. Niwa, T. Ushijima, A. Nagatsuma, T. Kuwata, T. Yoshino, T. Doi, A. Ochiai, A. Ohtsu, Comprehensive analyses using next-generation sequencing and immunohistochemistry enable precise treatment in advanced gastric cancer, Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 27 (2016) 127-133.
• Y. Kurokawa, N. Matsuura, Y. Kimura, S. Adachi, J. Fujita, H. Imamura, K. Kobayashi, Y. Yokoyama, M.N. Shaker, S. Takiguchi, M. Mori, Y. Doki, Multicenter large-scale study of prognostic impact of HER2 expression in patients with resectable gastric cancer, Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, (2014) .
• H.E. Lee, K.U. Park, S.B. Yoo, S.K. Nam, J. Park do, H.H. Kim, H.S. Lee, Clinical significance of intratumoral HER2 heterogeneity in gastric cancer, European journal of cancer, 49 (2013) 1448-1457.

Terms in the title (7)： 胃癌 ,  腫瘍 ,  分子生物学 ,  治療 ,  抵抗性機序 ,  治療戦略 ,  開発